VisionCare Specialist Eye Hospital Business Plan › Section 12 › Exit Strategy & Social Impact

12.1 Value-Creation Thesis

Value is created in three stages: de-risking (commissioning,
accreditation and reaching break-even); scaling (the utilisation ramp to
steady state and the Year-3 expansion); and optimisation (margin
maturity, premium-mix growth and the build-out of a referral moat). By
Year 5, the Company is a profitable, cash-generative, accredited
specialist hospital with a defensible market position — an asset class
actively sought by consolidators.

12.2 Exit Options

The promoters and equity investor have multiple, realistic routes to
liquidity:

• Trade sale to a national private-hospital group
  seeking to add or deepen ophthalmic capability — the most probable and
  highest-multiple exit, given the strategic value of a turnkey,
  accredited eye hospital with an established referral base.
• Secondary buy-out by a healthcare-focused
  private-equity fund attracted by stable cash flows and further roll-out
  potential into a multi-site platform.
• Management / clinician buy-out funded by the
  Company’s strong cash generation and supportable additional leverage at
  maturity.
• Dividend recapitalisation — returning capital to
  shareholders from accumulated cash while retaining ownership, given the
  closing cash balance of R154.3m by Year 5.

12.3 Indicative Exit Valuation

Applying a conservative EBITDA multiple range to Year-5 EBITDA of
R99.3m illustrates the potential equity value at exit. Even at the lower
end of the range, the implied enterprise value substantially exceeds the
total invested capital, before accounting for the net-cash position
accumulated by Year 5.

Table 12.1 — Indicative exit valuation on Year-5 EBITDA
(illustrative)

Note: Exit multiples are illustrative and depend
on prevailing market conditions, the Company’s growth profile at exit
and buyer synergies. They are provided to frame the order of magnitude
of potential value creation, not as a forecast.

12.4 Environmental, Social & Governance (ESG)

VisionCare is intrinsically an impact-aligned investment. Its core
activity — restoring and preserving sight — generates measurable social
return alongside financial return, making it well-suited to ESG-mandated
and development-finance capital.

• Social: subsidised community screening and
  outreach targeting at least 6,000 encounters annually by Year 3; direct
  contribution to reducing avoidable blindness; local employment and
  clinical-skills development.
• Governance: independent clinical governance,
  transparent outcomes reporting, POPIA-compliant data handling, and a
  board with independent representation.
• Environmental: responsible medical-waste
  management, energy-efficient building services, and resilience
  infrastructure that reduces reliance on diesel generation over
  time.

Alignment with national frameworks (VISION 2020 / 2030 In Sight) and
the global push for universal eye-health coverage positions VisionCare
to participate in public-private partnership and concessional-finance
opportunities that further de-risk the investment.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of VisionCare Specialist Eye Hospital (Pty) Ltd.